Sfoglia per Autore
Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study
2024 Martora, Fabrizio; Marasca, Claudio; Cacciapuoti, Sara; Fariello, Federica; Potestio, Luca; Battista, Teresa; Scalvenzi, Massimiliano; Megna, Matteo
Viral Reactivation Following COVID-19 Vaccination: a review of the current literature
2024 Martora, Fabrizio; Megna, Matteo; Battista, Teresa; Scalvenzi, Massimiliano; Villani, Alessia; Cacciapuoti, Sara; Potestio, Luca
ChatGPT and Dermatology: friends or foes?
2023 Potestio, Luca; Martora, Fabrizio; Villani, Alessia; Ruggiero, Angelo; Scalvenzi, Massimiliano; Megna, Matteo
Effectiveness of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis Located in Difficult-to-Treat Areas
2023 Cacciapuoti, Sara; Potestio, Luca; Guerrasio, Gianluca; Fabbrocini, Gabriella; Scalvenzi, Massimiliano; Ruggiero, Angelo; Caiazzo, Giuseppina; Megna, Matteo
Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire
2023 Camela, Elisa; Villani, Alessia; Ocampo Garza, Sonia Sofia; Costa, Claudia; Fabbrocini, Gabriella; Megna, Matteo; Potestio, Luca; Ruggiero, Angelo; Scalvenzi, Massimiliano
Herpes Zoster and COVID-19 Vaccination: A Narrative Review
2023 Potestio, Luca; Megna, Matteo; Villani, Alessia; Cacciapuoti, Sara; Scalvenzi, Massimiliano; Martora, Fabrizio
Nail Psoriasis: An Updated Review of Currently Available Systemic Treatments
2023 Battista, Teresa; Scalvenzi, Massimiliano; Martora, Fabrizio; Potestio, Luca; Megna, Matteo
The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature
2023 Martora, Fabrizio; Battista, Teresa; Ruggiero, Angelo; Scalvenzi, Massimiliano; Villani, Alessia; Megna, Matteo; Potestio, Luca
Hidradenitis Suppurativa and JAK Inhibitors: A Review of the Published Literature
2023 Martora, Fabrizio; Scalvenzi, Massimiliano; Ruggiero, Angelo; Potestio, Luca; Battista, Teresa; Megna, Matteo
Stardust Pattern as Evolution of Pigmented Spitz Nevi During Childhood
2023 Brunetti, Bruno; Briatico, Giulia; Scharf, Camila; Cabo, Horacio; Scalvenzi, Massimiliano; Barbato, Filomena; Savoia, Francesco; Thomas, Luc; Argenziano, Giuseppe; Brancaccio, Gabriella
Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data
2023 Martora, Fabrizio; Scalvenzi, Massimiliano; Battista, Teresa; Fornaro, Luigi; Potestio, Luca; Ruggiero, Angelo; Megna, Matteo
Teledermatology for Common Inflammatory Skin Conditions: The Medicine of the Future?
2023 Martora, Fabrizio; Fabbrocini, Gabriella; Megna, Matteo; Scalvenzi, Massimiliano; Battista, Teresa; Villani, Alessia; Potestio, Luca
Reply to ‘Impact of the French COVID ‐19 pandemic lockdown on newly diagnosed melanoma delay and severity’ by R. Molinier et al
2023 Ruggiero, Angelo; Martora, Fabrizio; Fornaro, Fabrizio; Scalvenzi, Massimiliano; Fabbrocini, Gabriella; Villani, Alessia
Reply to “A case of symmetrical drug‐related intertriginous and flexural exanthema‐like eruption associated with Pfizer COVID ‐19 vaccination” by Manaa et al
2022 Camela, Elisa; Scalvenzi, Massimiliano; Megna, Matteo; Potestio, Luca; Guerrasio, Gianluca; Fornaro, Luigi; Fabbrocini, Gabriella; Costa, Claudia
Hair Aging and Hair Disorders in Elderly Patients
2022 Villani, Alessia; Ferrillo, Maria; Fabbrocini, Gabriella; Ocampo-Garza, Sonia Sofía; Scalvenzi, Massimiliano; Ruggiero, Angelo
Coexistence of Bullous Pemphigoid and Pyoderma Gangrenosum
2022 Di Guida, Adriana; Fabbrocini, Gabriella; Scalvenzi, Massimiliano; De Fata Salvatores, Gaia
New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell Carcinoma
2022 Villani, A.; Potestio, L.; Fabbrocini, G.; Scalvenzi, M.
A 24-weeks real-world experience of dupilumab in adolescents with moderate-to-severe atopic dermatitis
2022 Napolitano, Maddalena; Fabbrocini, Gabriella; Potestio, Luca; Fontanella, Giuseppina; Picone, Vincenzo; Bennardo, Luigi; Scalvenzi, Massimiliano; Patruno, Cataldo
Vismodegib treatment in advanced basal cell carcinomas: Real-life experience
2022 Villani, A.; Fabbrocini, G.; Costa, C.; Scalvenzi, M.
Resistance to hedgehog inhibitors in basal cell carcinoma: strategies to adopt
2022 Villani, A.; Fabbrocini, G.; Di Vico, F.; Nastro, F.; Scalvenzi, M.
Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
---|---|---|---|---|
Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study | 1.1 Articolo in rivista | 2024 | Martora, Fabrizio; Marasca, Claudio; Cacciapuoti, Sara; Fariello, Federica; Potestio, Luca; Battista, Teresa; Scalvenzi, Massimiliano; Megna, Matteo | |
Viral Reactivation Following COVID-19 Vaccination: a review of the current literature | 1.8 Articolo in rassegna (review) | 2024 | Martora, Fabrizio; Megna, Matteo; Battista, Teresa; Scalvenzi, Massimiliano; Villani, Alessia; Cacciapuoti, Sara; Potestio, Luca | |
ChatGPT and Dermatology: friends or foes? | 1.1 Articolo in rivista | 2023 | Potestio, Luca; Martora, Fabrizio; Villani, Alessia; Ruggiero, Angelo; Scalvenzi, Massimiliano; Megna, Matteo | |
Effectiveness of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis Located in Difficult-to-Treat Areas | 1.1 Articolo in rivista | 2023 | Cacciapuoti, Sara; Potestio, Luca; Guerrasio, Gianluca; Fabbrocini, Gabriella; Scalvenzi, Massimiliano; Ruggiero, Angelo; Caiazzo, Giuseppina; Megna, Matteo | |
Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire | 1.1 Articolo in rivista | 2023 | Camela, Elisa; Villani, Alessia; Ocampo Garza, Sonia Sofia; Costa, Claudia; Fabbrocini, Gabriella; Megna, Matteo; Potestio, Luca; Ruggiero, Angelo; Scalvenzi, Massimiliano | |
Herpes Zoster and COVID-19 Vaccination: A Narrative Review | 1.8 Articolo in rassegna (review) | 2023 | Potestio, Luca; Megna, Matteo; Villani, Alessia; Cacciapuoti, Sara; Scalvenzi, Massimiliano; Martora, Fabrizio | |
Nail Psoriasis: An Updated Review of Currently Available Systemic Treatments | 1.8 Articolo in rassegna (review) | 2023 | Battista, Teresa; Scalvenzi, Massimiliano; Martora, Fabrizio; Potestio, Luca; Megna, Matteo | |
The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature | 1.1 Articolo in rivista | 2023 | Martora, Fabrizio; Battista, Teresa; Ruggiero, Angelo; Scalvenzi, Massimiliano; Villani, Alessia; Megna, Matteo; Potestio, Luca | |
Hidradenitis Suppurativa and JAK Inhibitors: A Review of the Published Literature | 1.8 Articolo in rassegna (review) | 2023 | Martora, Fabrizio; Scalvenzi, Massimiliano; Ruggiero, Angelo; Potestio, Luca; Battista, Teresa; Megna, Matteo | |
Stardust Pattern as Evolution of Pigmented Spitz Nevi During Childhood | 1.1 Articolo in rivista | 2023 | Brunetti, Bruno; Briatico, Giulia; Scharf, Camila; Cabo, Horacio; Scalvenzi, Massimiliano; Barbato, Filomena; Savoia, Francesco; Thomas, Luc; Argenziano, Giuseppe; Brancaccio, Gabriella | |
Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data | 1.8 Articolo in rassegna (review) | 2023 | Martora, Fabrizio; Scalvenzi, Massimiliano; Battista, Teresa; Fornaro, Luigi; Potestio, Luca; Ruggiero, Angelo; Megna, Matteo | |
Teledermatology for Common Inflammatory Skin Conditions: The Medicine of the Future? | 1.1 Articolo in rivista | 2023 | Martora, Fabrizio; Fabbrocini, Gabriella; Megna, Matteo; Scalvenzi, Massimiliano; Battista, Teresa; Villani, Alessia; Potestio, Luca | |
Reply to ‘Impact of the French COVID ‐19 pandemic lockdown on newly diagnosed melanoma delay and severity’ by R. Molinier et al | 1.7 Commento, erratum, replica e simili | 2023 | Ruggiero, Angelo; Martora, Fabrizio; Fornaro, Fabrizio; Scalvenzi, Massimiliano; Fabbrocini, Gabriella; Villani, Alessia | |
Reply to “A case of symmetrical drug‐related intertriginous and flexural exanthema‐like eruption associated with Pfizer COVID ‐19 vaccination” by Manaa et al | 1.7 Commento, erratum, replica e simili | 2022 | Camela, Elisa; Scalvenzi, Massimiliano; Megna, Matteo; Potestio, Luca; Guerrasio, Gianluca; Fornaro, Luigi; Fabbrocini, Gabriella; Costa, Claudia | |
Hair Aging and Hair Disorders in Elderly Patients | 1.1 Articolo in rivista | 2022 | Villani, Alessia; Ferrillo, Maria; Fabbrocini, Gabriella; Ocampo-Garza, Sonia Sofía; Scalvenzi, Massimiliano; Ruggiero, Angelo | |
Coexistence of Bullous Pemphigoid and Pyoderma Gangrenosum | 1.1 Articolo in rivista | 2022 | Di Guida, Adriana; Fabbrocini, Gabriella; Scalvenzi, Massimiliano; De Fata Salvatores, Gaia | |
New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell Carcinoma | 1.1 Articolo in rivista | 2022 | Villani, A.; Potestio, L.; Fabbrocini, G.; Scalvenzi, M. | |
A 24-weeks real-world experience of dupilumab in adolescents with moderate-to-severe atopic dermatitis | 1.1 Articolo in rivista | 2022 | Napolitano, Maddalena; Fabbrocini, Gabriella; Potestio, Luca; Fontanella, Giuseppina; Picone, Vincenzo; Bennardo, Luigi; Scalvenzi, Massimiliano; Patruno, Cataldo | |
Vismodegib treatment in advanced basal cell carcinomas: Real-life experience | 1.1 Articolo in rivista | 2022 | Villani, A.; Fabbrocini, G.; Costa, C.; Scalvenzi, M. | |
Resistance to hedgehog inhibitors in basal cell carcinoma: strategies to adopt | 1.1 Articolo in rivista | 2022 | Villani, A.; Fabbrocini, G.; Di Vico, F.; Nastro, F.; Scalvenzi, M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile